Acute Promyelocytic Leukemia  >>  GEM 640  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GEM 640 / Pharmascience
NCT01018069 / 2009-013669-25: AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Terminated
2
60
US, Canada, Europe
AEG35156
Aegera Therapeutics
Leukemia
10/10
10/10

Download Options